Company / Gross Margin
Valion Bio, Inc. Gross Margin History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
24.4%
FY2024
5-year range
-3.0% / 24.4%
FY2022-FY2024
Trend
+50.2%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -3.0% to 24.4% over the past 2 years.
Based on SEC 10-K filings.
24.4% in FY2024.
Improved from -3.0% to 24.4% over the past 2 years.
Gross Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, gross margin increased 50.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score -10.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | 24.4% | +50.2% |
| FY2023 | 16.3% | +638.1% |
| FY2022 | -3.0% | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026